Castle Biosciences (CSTL) Competitors $25.75 -0.40 (-1.53%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$25.74 0.00 (-0.02%) As of 02/21/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CSTL vs. LFST, PRVA, CON, TDOC, ARDT, WGS, ADUS, PACS, PGNY, and GRALShould you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include LifeStance Health Group (LFST), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Teladoc Health (TDOC), Ardent Health Partners (ARDT), GeneDx (WGS), Addus HomeCare (ADUS), PACS Group (PACS), Progyny (PGNY), and Grail (GRAL). These companies are all part of the "healthcare" industry. Castle Biosciences vs. LifeStance Health Group Privia Health Group Concentra Group Holdings Parent Teladoc Health Ardent Health Partners GeneDx Addus HomeCare PACS Group Progyny Grail LifeStance Health Group (NASDAQ:LFST) and Castle Biosciences (NASDAQ:CSTL) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations. Do insiders and institutionals hold more shares of LFST or CSTL? 85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 92.6% of Castle Biosciences shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 7.2% of Castle Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer LFST or CSTL? LifeStance Health Group currently has a consensus target price of $8.70, indicating a potential upside of 12.99%. Castle Biosciences has a consensus target price of $40.29, indicating a potential upside of 56.45%. Given Castle Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Castle Biosciences is more favorable than LifeStance Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeStance Health Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Castle Biosciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor LFST or CSTL? Castle Biosciences received 80 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 65.00% of users gave Castle Biosciences an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote. CompanyUnderperformOutperformLifeStance Health GroupOutperform Votes1126.19% Underperform Votes3173.81% Castle BiosciencesOutperform Votes9165.00% Underperform Votes4935.00% Is LFST or CSTL more profitable? Castle Biosciences has a net margin of 1.95% compared to LifeStance Health Group's net margin of -7.90%. Castle Biosciences' return on equity of 1.47% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets LifeStance Health Group-7.90% -6.66% -4.51% Castle Biosciences 1.95%1.47%1.27% Which has more risk and volatility, LFST or CSTL? LifeStance Health Group has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Castle Biosciences has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Does the media favor LFST or CSTL? In the previous week, Castle Biosciences had 5 more articles in the media than LifeStance Health Group. MarketBeat recorded 6 mentions for Castle Biosciences and 1 mentions for LifeStance Health Group. Castle Biosciences' average media sentiment score of 1.06 beat LifeStance Health Group's score of -0.50 indicating that Castle Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Castle Biosciences 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, LFST or CSTL? Castle Biosciences has lower revenue, but higher earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Castle Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeStance Health Group$1.06B2.79-$186.26M-$0.26-29.62Castle Biosciences$219.79M3.28-$57.47M$0.20128.76 SummaryCastle Biosciences beats LifeStance Health Group on 15 of the 17 factors compared between the two stocks. Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CSTL vs. The Competition Export to ExcelMetricCastle BiosciencesMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$721.26M$3.14B$5.82B$9.09BDividend YieldN/A20.51%4.77%3.84%P/E Ratio128.7610.9318.9215.38Price / Sales3.28169.13453.2984.08Price / CashN/A385.9743.8437.22Price / Book1.774.847.644.65Net Income-$57.47M-$22.21M$3.18B$245.69M7 Day Performance-5.75%-4.33%-1.95%-2.67%1 Month Performance-3.27%-2.39%-0.23%-2.16%1 Year Performance5.71%13.74%16.69%12.90% Castle Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CSTLCastle Biosciences2.1195 of 5 stars$25.75-1.5%$40.29+56.4%+4.3%$732.39M$219.79M128.76540News CoveragePositive NewsLFSTLifeStance Health Group1.5331 of 5 stars$7.97-0.3%$8.70+9.2%+22.0%$3.05B$1.21B-30.659,325Upcoming EarningsNews CoveragePositive NewsPRVAPrivia Health Group3.2393 of 5 stars$25.24+1.5%$24.94-1.2%+20.0%$3.03B$1.72B252.431,102News CoverageCONConcentra Group Holdings ParentN/A$22.69-0.6%$28.63+26.1%N/A$2.89B$1.84B0.0011,000Positive NewsTDOCTeladoc Health2.0385 of 5 stars$14.36+6.3%$12.08-15.9%-26.4%$2.47B$2.60B-2.495,600Analyst ForecastNews CoverageGap DownHigh Trading VolumeARDTArdent Health PartnersN/A$14.79-1.7%$21.55+45.7%N/A$2.11B$5.41B0.0024,200Upcoming EarningsPositive NewsWGSGeneDx2.0371 of 5 stars$76.35-2.1%$70.67-7.4%+1,278.8%$2.10B$267.23M-24.551,200Earnings ReportAnalyst ForecastNews CoverageADUSAddus HomeCare4.8027 of 5 stars$113.22-2.0%$134.22+18.5%+19.5%$2.05B$1.06B25.9134,846Upcoming EarningsNews CoveragePositive NewsPACSPACS Group4.0187 of 5 stars$13.41-4.1%$34.00+153.5%N/A$2.04B$3.11B0.0032,433News CoveragePGNYProgyny2.6156 of 5 stars$22.36+1.9%$25.83+15.5%-42.4%$1.90B$1.09B38.55310GRALGrail1.0098 of 5 stars$55.02+4.6%$16.00-70.9%N/A$1.85BN/A0.001,360Earnings ReportNews CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies LifeStance Health Group Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives Teladoc Health Alternatives Ardent Health Partners Alternatives GeneDx Alternatives Addus HomeCare Alternatives PACS Group Alternatives Progyny Alternatives Grail Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CSTL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSTL Stock Alerts